Kozak Kevin R, Adams Judith, Krejcarek Stephanie J, Tarbell Nancy J, Yock Torunn I
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):179-86. doi: 10.1016/j.ijrobp.2008.06.1942. Epub 2008 Nov 18.
We compared tumor and normal tissue dosimetry of proton radiation therapy with intensity-modulated radiation therapy (IMRT) for pediatric parameningeal rhabdomyosarcomas (PRMS).
To quantify dosimetric differences between contemporary proton and photon treatment for pediatric PRMS, proton beam plans were compared with IMRT plans. Ten patients treated with proton radiation therapy at Massachusetts General Hospital had IMRT plans generated. To facilitate dosimetric comparisons, clinical target volumes and normal tissue volumes were held constant. Plans were optimized for target volume coverage and normal tissue sparing.
Proton and IMRT plans provided acceptable and comparable target volume coverage, with at least 99% of the CTV receiving 95% of the prescribed dose in all cases. Improved dose conformality provided by proton therapy resulted in significant sparing of all examined normal tissues except for ipsilateral cochlea and mastoid; ipsilateral parotid gland sparing was of borderline statistical significance (p = 0.05). More profound sparing of contralateral structures by protons resulted in greater dose asymmetry between ipsilateral and contralateral retina, optic nerves, cochlea, and mastoids; dose asymmetry between ipsilateral and contralateral parotids was of borderline statistical significance (p = 0.05).
For pediatric PRMS, superior normal tissue sparing is achieved with proton radiation therapy compared with IMRT. Because of enhanced conformality, proton plans also demonstrate greater normal tissue dose distribution asymmetry. Longitudinal studies assessing the impact of proton radiotherapy and IMRT on normal tissue function and growth symmetry are necessary to define the clinical consequences of these differences.
我们比较了质子放射治疗与调强放射治疗(IMRT)对小儿脑膜旁横纹肌肉瘤(PRMS)的肿瘤和正常组织剂量学。
为了量化当代质子和光子治疗小儿PRMS的剂量学差异,将质子束计划与IMRT计划进行了比较。在马萨诸塞州总医院接受质子放射治疗的10例患者生成了IMRT计划。为便于进行剂量学比较,临床靶体积和正常组织体积保持不变。计划针对靶体积覆盖和正常组织保护进行了优化。
质子和IMRT计划提供了可接受且可比的靶体积覆盖,所有病例中至少99%的临床靶体积(CTV)接受了95%的处方剂量。质子治疗提供的更好的剂量适形性导致除同侧耳蜗和乳突外的所有检查的正常组织得到显著保护;同侧腮腺的保护具有边缘统计学意义(p = 0.05)。质子对侧结构的保护更显著,导致同侧和对侧视网膜、视神经、耳蜗和乳突之间的剂量不对称性更大;同侧和对侧腮腺之间的剂量不对称性具有边缘统计学意义(p = 0.05)。
对于小儿PRMS,与IMRT相比,质子放射治疗能更好地保护正常组织。由于适形性增强,质子计划也显示出更大的正常组织剂量分布不对称性。需要进行纵向研究来评估质子放疗和IMRT对正常组织功能和生长对称性的影响,以确定这些差异的临床后果。